3种方案治疗小儿呼吸道感染的成本-效果分析

Cost-Effectiveness Analysis of 3 Therapeutic Schemes for Respiratory Tract Infection in Children

目的:比较3种方案治疗小儿呼吸道感染的经济学效果。方法:采用回顾性调查方法,对阿莫西林/克拉维酸钾(A组)、头孢呋辛钠+利巴韦林(B组)和头孢哌酮/舒巴坦(C组)治疗小儿呼吸道感染进行成本-效果分析。结果:A、B、C组成本分别为855.46、798.90、773.00元,总有效率分别为93.75%、96.00%、95.83%(P>0.05),成本-效果比分别为912.5、832.2、806.6。结论:C组方案较佳。

OBJECTIVE： To compare the pharmacoeconomics outcome of 3 schemes in treating respiratory tract infection （RTI） in children.METHODS： This is a retrospective study in which a cost effectiveness analysis were performed on the following 3 schemes in treating RTI in children：amoxicillin/potassium clavulanate（Group A）,cefuroxime plus ribavirin（Group B）, and cefoperazone/sulbactam（Group C） .RESULTS： The costs for Group A, B and C were 855.46 yuan, 798.90 yuan and 773.00 yuan, respectively;the effective rates stood at 93.75% ,96.00% and 95.83% ,respectively（P〉0.05）,and the cost-effectiveness ratio were 912.5,832.2 and 806.6, respectively.CONCLUSION ： Scheme C was superior among the three.